- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Medartis Holding AG (MEDA)
The Medartis share price today is 84.50, view SIX MEDA stock exchange data. Track the latest Medartis share price with real-time updates on MEDA stock performance including market cap, day range, 52-week range and dividend yield. Access MEDA charts, earnings dates and analyst estimates to support your investment decisions.
84.50
-3.70(-4.20%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
83.90
88.00
52 wk Range
70.60
97.50
MEDA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
83.9088.00
52 wk Range
70.6097.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
MEDA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
98.33
Upside
+16.37%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Medartis receives Investment Bank Analyst Rating Update- Investing.com
Pro
Medartis receives Investment Bank Analyst Rating Update- Investing.com
Pro
Medartis receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Medartis receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Medartis receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
3 Buy
1 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 98.33
(+16.37% Upside)
Earnings
Latest Release
17-03-2026
EPS / Forecast
0.79 / --
Revenue / Forecast
146.22M / --
Compare MEDA to Peers and Sector
Metrics to compare | MEDA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMEDAPeersSector | |
|---|---|---|---|---|
P/E Ratio | 131.5x | 22.8x | −0.4x | |
PEG Ratio | 0.94 | 0.01 | 0.00 | |
Price/Book | 4.0x | 3.2x | 2.6x | |
Price / LTM Sales | 4.1x | 1.8x | 3.1x | |
Upside (Analyst Target) | 10.2% | 7.2% | 48.5% | |
Fair Value Upside | Unlock | 14.8% | 5.8% | Unlock |
Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company’s medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. It provides products for the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for upper and lower extremities, mandible, midface, orthognathic under the APTUS and MODUS names, as well as CMX services through web portal, and kerimedical products. The company was incorporated in 1997 and is headquartered in Basel, Switzerland.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Medartis (MEDA) Share Price Today?
The Medartis share price today is 84.50.
What is the current Medartis (MEDA) share price and day range?
As of 10-08-2026, the Medartis share price is 84.50, with a previous close of 88.20. The share price has ranged from 83.90 to 88.00 today, while the 52-week range spans from 70.60 to 97.50.
What Is the Medartis Market Cap?
As of today, Medartis market cap is 1.05B.
What Is the Medartis (MEDA) Share Price Target?
The average 12-month share price target for Medartis is 98.33, with a high estimate of 102 and a low estimate of 96. 3 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +16.37% Upside potential.
What Is Medartis's Earnings Per Share (TTM)?
The Medartis EPS (TTM) is 0.67.
From a Technical Analysis Perspective, Is MEDA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Medartis Trade On?
Medartis is listed and trades on the Switzerland Stock Exchange.
What Is the Stock Symbol for Medartis?
The stock symbol for Medartis is "MEDA."
How Many Times Has Medartis Stock Split?
Medartis has split 0 times.
How Many Employees Does Medartis Have?
Medartis has 1259 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.